Loading...
0

Africa Large Volume Parenterals (LVP) Market by Treatment Type (Fluid Balance Injections, Therapeutic Injections, and Nutritious Injections), Route of Administration (Intravenous, Intramuscular, Subcutaneous, and Other), and Capacity (100 ml, 250 ml, 500 ml, 1000 ml, and 2000 ml) - Global Opportunity Analysis and Industry Forecast, 2018-2024
Update Available On-Demand

LI_184613
Pages: 85
Apr 2018 | 2676 Views
 
Author(s) : Amrita Srivastava, & Pallavi Jaiswal
Tables: 25
Charts: 23
 

Africa Large Volume Parenterals (LVP) Market Overview:

The Africa large volume parenterals (LVP) market was valued at $662 million in 2017, and is expected to reach $1,133 million by 2024, growing at a CAGR of 7.9% from 2018 to 2024. In terms of volume, the market garnered 291,095 thousand units in 2017, and is expected to reach 582,780 thousand units by 2024, growing with a CAGR of 10.4% from 2018 to 2024.

Get more information on this report : Request Sample Pages

The growth of the Africa large volume parenterals market is driven by rise in prevalence of chronic diseases such as cancer, HIV, and other non-communicable diseases; rapid surge in number of surgeries; and rise in risk of malnutrition. However, preference for enteral route of drug administration of therapeutic & nutritional needs and high risk of infection/allergic reaction during a parenteral administration are expected to impede the market growth. Conversely, upsurge in demand for palliative care services in Africa is expected to offer opportunities for market expansion during the forecast period.

Africa Large Volume Parenterals Market Segmentation

The Africa large volume parenterals market is segmented on the basis of treatment type, route of administration, capacity, and country. On the basis of treatment type, the market is classified into fluid balance injections, therapeutic injections, and nutritious injections. Depending on route of administration, it is fragmented into intravenous, intramuscular, subcutaneous, and other routes. LVP are commercially available in 100 ml, 250 ml, 500 ml, 1000 ml, and 2000 ml bottles. Country wise, the market is analyzed across South Africa, Zimbabwe, Namibia, and rest of Africa.

Segment review

Fluid balance injection is the most commonly used treatment type, owing its wide applications such as fluid resuscitation, routine maintenance, replacement, and redistribution. Fluid resuscitation refers to the restoration of circulation to vital organs after loss of intravascular fluids due to bleeding, plasma loss, or excessive external fluid & electrolyte loss. Parenteral preparations are required by patients who cannot meet their normal fluid or electrolyte needs by oral/enteral routes. These patients need to undergo IV therapy for routine maintenance of bodily fluids and electrolytes. In addition, LVP may be needed for internal fluid distribution changes in case of edema or abnormal fluid handling by the organ systems. Fluid redistribution is required in patients who are critically ill, septic, with major cardiac, liver or renal comorbidity, or after a major surgery.

by treatment type

Get more information on this report : Request Sample Pages

Based on route of administration, the market is fragmented into intravenous, intramuscular, subcutaneous, and other routes. Intravenous (IV) route is the most commonly used route, and serves as the fastest way to deliver large volume parenterals, as the drug is easily carried throughout the body with the help of circulation.

Furthermore, the market is analyzed for volume of large volume parenterals by capacity, i.e. 100 ml, 250 ml, 500 ml, 1000 ml, and 2000 ml bottles.

by route

Get more information on this report : Request Sample Pages

Snapshot of South Africa large volume parenterals market

South Africa has one of the most advanced palliative care systems in Africa, as it has an extensive network of hospice organizations that provide care to people suffering from chronic and life-threatening illnesses. For instance, palliative care is required in the end stage of cancer, lung diseases, diabetes, and cardiac diseases. In addition, rise in prevalence of non-communicable diseases is expected to drive the market growth. However, according to the South African Health News Service, most of the palliative care facilities in South Africa focus on cancer and HIV patients as compared to other conditions. Thus, South African healthcare organizations are expected to expand their palliative care facilities for patients suffering from other non-communicable or life-threatening disorders, which would further propel the growth of the market.

by country

Get more information on this report : Request Sample Pages

The key local players within Africa large volume parenterals market include Abacus Parenteral Drugs Limited, Erongo Med, Datlabs Private Limited, Addis Pharmaceuticals Factory PLC, Pharmacure PLC, Mascareignes Pharmaceutical Manufacturing Co. Ltd. (operates as a subsidiary of Parenteral Drug (India) Ltd.), and Adcock Ingram Holdings Ltd.

Key Benefits

  • The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2017 to 2023, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Analysis by route of administration helps to understand the various routes for administration of parenteral drugs within the body.
  • Comprehensive analysis of major countries within Africa is provided to determine the prevailing opportunities.
  • Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the market.

Africa Large Volume Parenterals (LVP) Market Key Segments:

By Treatment Type

  • Fluid Balance Injections
  • Therapeutic Injections
  • Nutritious Injections

By Route of Administration

  • Intravenous
  • Intramuscular
  • Subcutaneous
  • Others

By Capacity

  • 100 ml
  • 250 ml
  • 500 ml
  • 1000 ml
  • 2000 ml

By Country

  • South Africa
  • Zimbabwe
  • Namibia
  • Rest of Africa
 

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. Key Findings

3.2.1. Top investment pockets
3.2.2. Top player positioning, 2016

3.3. MARKET DYNAMICS

3.3.1. Drivers

3.3.1.1. Increase in number of surgical procedures
3.3.1.2. Rise in prevalence of chronic diseases
3.3.1.3. Rise in risk of malnutrition

3.3.2. Restraints

3.3.2.1. Risk of allergic reaction and infection
3.3.2.2. Preference for enteral route of administration

3.3.3. Opportunities

3.3.3.1. Upsurge in demand for palliative care

CHAPTER 4: AFRICA LARGE VOLUME PARENTERALS MARKET, BY TREATMENT TYPE

4.1. Overview

4.1.1. Market size and forecast

4.2. Fluid balance injections

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast

4.3. Therapeutic Injections

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast

4.4. Nutritious injections

4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast

CHAPTER 5: AFRICA LARGE VOLUME PARENTERALS MARKET, BY ROUTE OF ADMINISTRATION

5.1. Overview

5.1.1. Market size and forecast

5.2. Intravenous

5.2.1. Market size and forecast

5.3. Intramuscular

5.3.1. Market size and forecast

5.4. Subcutaneous

5.4.1. Market size and forecast

5.5. Other routes

5.5.1. Market size and forecast

CHAPTER 6: AFRICA LARGE VOLUME PARENTERALS MARKET, BY CAPACITY

6.1. Overview

6.1.1. Market size and forecast

6.2. 100 ml

6.2.1. Market size and forecast

6.3. 250 ml

6.3.1. Market size and forecast

6.4. 500 ml

6.4.1. Market size and forecast

6.5. 1000 ml

6.5.1. Market size and forecast

6.6. 2000 ml

6.6.1. Market size and forecast

CHAPTER 7: AFRICA LARGE VOLUME PARENTERALS MARKET, BY COUNTRY

7.1. Overview

7.1.1. Market size and forecast

7.2. South Africa

7.2.1. Market size and forecast

7.3. Zimbabwe

7.3.1. Market size and forecast

7.4. Namibia

7.4.1. Market size and forecast

7.5. Rest of Africa

7.5.1. Market size and forecast

CHAPTER 8: COMPANY PROFILE

8.1. Parenteral Drugs (India) Ltd.

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance

8.2. Adcock Ingram Holdings Ltd.

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance

8.3. Pharmacure PLC

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Product portfolio

8.4. Datlabs Private Limited

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio

8.5. Erongo Med

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio

8.6. Addis Pharmaceutical Factory PLC.

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Key strategic moves and developments

8.7. Abacus Parenteral Drugs Limited

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Product portfolio

LIST OF TABLES

TABLE 01. TOTAL SURGICAL NEED IN SUB-SAHARAN AFRICA, 2010
TABLE 02. MINIMUM UNMET NEED FOR SURGICAL CASES IN SUB-SAHARAN AFRICA, 2010
TABLE 03. AFRICA LARGE VOLUME PARENTERALS MARKET, BY TREATMENT TYPE, 2017-2024 ($MILLION)
TABLE 04. AFRICA LARGE VOLUME PARENTERALS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 ($MILLION)
TABLE 05. OTHER ROUTES OF PARENTERAL ADMINISTRATION
TABLE 06. AFRICA LARGE VOLUME PARENTERALS VALUE MARKET, BY CAPACITY, 2017-2024 ($MILLION)
TABLE 07. AFRICA LARGE VOLUME PARENTERALS VOLUME MARKET, BY CAPACITY, 2017-2024 (THOUSAND UNITS)
TABLE 08. AFRICA LARGE VOLUME PARENTERALS MARKET, BY COUNTRY, 2017-2024 ($MILLION)
TABLE 09. PDIL: COMPANY SNAPSHOT
TABLE 10. PDIL: PRODUCT CATEGORY
TABLE 11. PDIL: PRODUCT PORTFOLIO
TABLE 12. ADCOCK INGRAM: COMPANY SNAPSHOT
TABLE 13. ADCOCK INGRAM: OPERATING SEGMENTS
TABLE 14. PHARMACURE: COMPANY SNAPSHOT
TABLE 15. DATLABS: COMPANY SNAPSHOT
TABLE 16. DATLABS: PRODUCT CATEGORY
TABLE 17. DATLABS: PRODUCT PORTFOLIO
TABLE 18. ERONGO MED: COMPANY SNAPSHOT
TABLE 19. ERONGO MED: PRODUCT CATEGORY
TABLE 20. ERONGO MED: PRODUCT PORTFOLIO
TABLE 21. APF: COMPANY SNAPSHOT
TABLE 22. APF: PRODUCT CATEGORY
TABLE 23. APF: PRODUCT PORTFOLIO
TABLE 24. APDL: COMPANY SNAPSHOT
TABLE 25. APDL: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01. AFRICA LVP MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS, 2017
FIGURE 03. TOP PLAYER POSITIONING, 2017
FIGURE 04. AFRICA LARGE VOLUME PARENTERALS MARKET FOR FLUID BALANCE INJECTIONS, 2017-2024 ($MILLION)
FIGURE 05. AFRICA LARGE VOLUME PARENTERALS MARKET FOR THERAPEUTIC INJECTIONS, 2017-2024 ($MILLION)
FIGURE 06. AFRICA LARGE VOLUME PARENTERALS MARKET FOR NUTRITIOUS INJECTIONS, 2017-2024 ($MILLION)
FIGURE 07. AFRICA LARGE VOLUME PARENTERALS MARKET, BY ROUTE OF ADMINISTRATION
FIGURE 08. AFRICA LARGE VOLUME PARENTERALS MARKET FOR INTRAVENOUS ROUTE OF ADMINISTRATION, 2017-2024 ($MILLION)
FIGURE 09. AFRICA LARGE VOLUME PARENTERALS MARKET FOR INTRAMUSCULAR ROUTE OF ADMINISTRATION, 2017-2024 ($MILLION)
FIGURE 10. AFRICA LARGE VOLUME PARENTERALS MARKET FOR SUBCUTANEOUS ROUTE OF ADMINISTRATION, 2017-2024 ($MILLION)
FIGURE 11. AFRICA LARGE VOLUME PARENTERALS MARKET FOR OTHER ROUTES OF ADMINISTRATION, 2017-2024 ($MILLION)
FIGURE 12. AFRICA LARGE VOLUME PARENTERALS MARKET FOR 100 ML BOTTLES, BY VALUE AND VOLUME, 2017-2024 ($MILLION)
FIGURE 13. AFRICA LARGE VOLUME PARENTERALS MARKET FOR 250 ML BOTTLES, BY VALUE AND VOLUME, 2017-2024 ($MILLION)
FIGURE 14. AFRICA LARGE VOLUME PARENTERALS MARKET FOR 500 ML BOTTLES, BY VALUE AND VOLUME, 2017-2024 ($MILLION)
FIGURE 15. AFRICA LARGE VOLUME PARENTERALS MARKET FOR 1000 ML BOTTLES, BY VALUE AND VOLUME, 2017-2024 ($MILLION)
FIGURE 16. AFRICA LARGE VOLUME PARENTERALS MARKET FOR 2000 ML BOTTLES, BY VALUE AND VOLUME, 2017-2024 ($MILLION)
FIGURE 17. SOUTH AFRICA LARGE VOLUME PARENTERALS MARKET, 2017-2024 ($MILLION)
FIGURE 18. ZIMBABWE LARGE VOLUME PARENTERALS MARKET, 2017-2024 ($MILLION)
FIGURE 19. NAMIBIA LARGE VOLUME PARENTERALS MARKET, 2017-2024 ($MILLION)
FIGURE 20. REST OF AFRICA LARGE VOLUME PARENTERALS MARKET, 2017-2024 ($MILLION)
FIGURE 21. PDIL: NET SALES, 2014-2016 ($MILLION)
FIGURE 22. ADCOCK INGRAM: NET SALES, 2015-2017 ($MILLION)
FIGURE 23. ADCOCK INGRAM: REVENUE SHARE BY SEGMENT, 2017 (%)

 
 

The adoption of large volume parenterals in Africa is expected to increase in the near future, owing to high prevalence rate of chronic disorders such as cancer, HIV/AIDS, and other non-communicable diseases. The LVP market has gained the traction among the healthcare providers, owing to rapid rise in number of surgeries. In addition, surge in risk of malnutrition in Africa significantly drives the market growth.

South Africa is expected to dominate the Africa LVP market during the analysis period. In addition, Namibia is expected to offer lucrative opportunities to market players in the coming future.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry

Download Sample

Request Customization

Download Sample

OR

Purchase Full Report of
Africa Large Volume Parenterals (LVP) Market- Global Opportunity Analysis and Industry Forecast, 2018-2024

  • Data Pack
  • $2,074
  • Restricted to one authorized user
  • One print only
  • Available in Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $2,900
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $3,483
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $4,858
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 
Download Sample

Buy Full Version
"Africa Large Volume Parenterals (LVP) Market"
Purchase Enquiry